Cargando…

CD105 Expression on CD34-Negative Spindle-Shaped Stromal Cells of Primary Tumor Is an Unfavorable Prognostic Marker in Early Breast Cancer Patients

Several studies have confirmed that the breast tumor microenvironment drives cancer progression and metastatic development. The aim of our research was to investigate the prognostic significance of the breast tumor microenvironment in untreated early breast cancer patients. Therefore, we analyzed th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martinez, Leandro Marcelo, Labovsky, Vivian, de Luján Calcagno, María, Davies, Kevin Mauro, Rivello, Hernán Garcia, Bianchi, Maria Silvia, Wernicke, Alejandra, Vallone, Valeria Beatriz Fernández, Chasseing, Norma Alejandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372565/ https://www.ncbi.nlm.nih.gov/pubmed/25803686 http://dx.doi.org/10.1371/journal.pone.0121421

Ejemplares similares

CD105 expression in cancer-associated fibroblasts: a biomarker for bone metastasis in early invasive ductal breast cancer patients
por: Giorello, María Belén, et al.
Publicado: (2023)

Prognostic significance of TRAIL-R3 and CCR-2 expression in tumor epithelial cells of patients with early breast cancer
por: Labovsky, Vivian, et al.
Publicado: (2017)

Expression of osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, tumor necrosis factor-related apoptosis-inducing ligand, stromal cell-derived factor-1 and their receptors in epithelial metastatic breast cancer cell lines
por: Labovsky, Vivian, et al.
Publicado: (2012)

Correction: CD105 Expression on CD34-Negative Spindle-Shaped Stromal Cells of Primary Tumor Is an Unfavorable Prognostic Marker in Early Breast Cancer Patients
Publicado: (2015)

An Immunohistochemical Survey to Evaluate the Expression of CD105 and CD34 in Ameloblastoma and Odontogenic Keratocyst
por: Jamshidi, Shokoofeh, et al.
Publicado: (2014)

Immunohistochemical Comparison of the Expression of CD34 and CD105 in Odontogenic Keratocyst and Dentigerous Cyst
por: Jamshidi, Shokoofeh, et al.
Publicado: (2017)

Phenotypic Characterization of Adherent Cells Population CD34+ CD90+ CD105+ Derived from Wharton’s Jelly
por: Walecka, Irena, et al.
Publicado: (2017)

CD34 and CD105 Microvessels in Resected Bone Specimen May Implicate Wound Healing in MRONJ
por: Marcianò, Antonia, et al.
Publicado: (2021)

Human Cardiac Mesenchymal Stromal Cells with CD105(+)CD34(-) Phenotype Enhance the Function of Post-Infarction Heart in Mice
por: Czapla, Justyna, et al.
Publicado: (2016)

Histomorphological and Morphometric Evaluation of Microvessel Density in Nodal Non-Hodgkin Lymphoma Using CD34 and CD105
por: Kataria, Sant Prakash, et al.
Publicado: (2021)

Expression and clinical significance of CD31, CD34, and CD105 in pulmonary ground glass nodules with different vascular manifestations on CT
por: Guo, Chen-ran, et al.
Publicado: (2022)

Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression
por: Paschoal, Juliana Passos, et al.
Publicado: (2014)

CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34
por: Miyata, Yasuyoshi, et al.
Publicado: (2013)

Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Biological Carriers for Drug Delivery in Cancer Therapy
por: Sanmartin, María Cecilia, et al.
Publicado: (2022)

High frequency of CD34+CD38-/low immature leukemia cells is correlated with unfavorable prognosis in acute myeloid leukemia
por: Plesa, Adriana, et al.
Publicado: (2017)

A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion
por: Miao, Yanming, et al.
Publicado: (2016)

Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma
por: Di Paolo, Virginia, et al.
Publicado: (2018)

Expression of endoglin (CD105) in cervical cancer
por: Zijlmans, H J, et al.
Publicado: (2009)

Senescent mesenchymal stem/stromal cells in pre-metastatic bone marrow of untreated advanced breast cancer patients
por: BORZONE, FRANCISCO RAÚL, et al.
Publicado: (2023)

Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy
por: Miyata, Yasuyoshi, et al.
Publicado: (2015)

CD105(+)CD90(+)CD13(+) identifies a clonogenic subset of adventitial lung fibroblasts
por: Kadefors, Måns, et al.
Publicado: (2021)

CD105 (Endoglin) as negative prognostic factor in AML
por: Kauer, Joseph, et al.
Publicado: (2019)

Spontaneous Osteoclastogenesis, a risk factor for bone metastasis in advanced luminal A-type breast cancer patients
por: Fernández Vallone, Valeria, et al.
Publicado: (2023)

Short-Spindled Cell Haemangioblastoma with CD34 Expression: New Histopathological Variant or Just a Stochastic Cytological Singularity?
por: Salazar, Miguel Fdo., et al.
Publicado: (2016)

ENDOGLIN/CD105 is expressed in KIT positive cells in the gut and in gastrointestinal stromal tumours
por: Gromova, Petra, et al.
Publicado: (2012)

PROGNOSTIC ROLE OF CD44 EXPRESSION AND NEOVASCULARIZATION DETERMINED BY ENDOGLIN (CD105) IN GLIOBLASTOMA PATIENTS
por: Mihić, Josip, et al.
Publicado: (2019)

Antagonizing CD105 enhances radiation sensitivity in prostate cancer
por: Madhav, Anisha, et al.
Publicado: (2018)

Identification of CD105 (endoglin) as novel risk marker in CLL
por: Greiner, Sarah M., et al.
Publicado: (2022)

Ex vivo identification and characterization of a population of CD13(high) CD105(+) CD45(−) mesenchymal stem cells in human bone marrow
por: Muñiz, Carmen, et al.
Publicado: (2015)

Molecular pathways of early CD105-positive erythroid cells as compared with CD34-positive common precursor cells by flow cytometric cell-sorting and gene expression profiling
por: Machherndl-Spandl, S, et al.
Publicado: (2013)

Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis
por: Li, C, et al.
Publicado: (2003)

Neuroprotection of the hypoxic-ischemic mouse brain by human CD117(+)CD90(+)CD105(+) amniotic fluid stem cells
por: Corcelli, Michelangelo, et al.
Publicado: (2018)

Osteogenic Potential of Mouse Adipose-Derived Stem Cells Sorted for CD90 and CD105 In Vitro
por: Yamamoto, Maiko, et al.
Publicado: (2014)

Evaluation of microvessel density with CD31 and CD105 in patients with psoriasis under methotrexate and acitretin therapy
por: Zemheri, Ebru, et al.
Publicado: (2020)

Cd34+ Stromal Cells/Telocytes in Normal and Pathological Skin
por: Díaz-Flores, Lucio, et al.
Publicado: (2021)

Assessment of Micro-vessel Density in Brain Gliomaby CD105 Expression
por: Saffar, Hiva, et al.
Publicado: (2018)

Study of expression of endoglin (CD105) in oral squamous cell carcinoma
por: Mahapatra, Niva, et al.
Publicado: (2021)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

Induction of Expression of CD271 and CD34 in Mesenchymal Stromal Cells Cultured as Spheroids
por: Bellagamba, Bruno Corrêa, et al.
Publicado: (2018)

CD34 Expression in the Stromal Cells of Alveolar Adenoma
por: De Rosa, Nicolina, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_65fvcbs9kgndgucjgbmglvi9on